Sex Differences in Heart Failure Mortality with Preserved, Mildly Reduced and Reduced Ejection Fraction: A Retrospective, Single-Center, Large-Cohort Study

Imagem de Miniatura
Arquivos
art_MANSUR_Sex_Differences_in_Heart_Failure_Mortality_with_Preserved_2022.PDF (817.46 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
Citação
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, v.19, n.23, article ID 16171, 13p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Heart failure (HF) is one of the leading causes of death worldwide. Studies show that women have better survival rates than men despite higher hospitalizations. However, little is known about differences in mortality and predictors of death in women and men with HF with preserved (HFpEF), mildly reduced (HFmrEF), and reduced ejection fraction (HFrEF). Methods: From February 2017 to September 2020, mortality and predictors of death were analyzed in women and men with HF. Baseline data included clinical characteristics and echocardiographic findings. Results: A total of 11,282 patients, 63.9 +/- 14.4 years, including 6256 (55.4%) males, were studied. Females were older, had a higher baseline mean left ventricular ejection fraction (LVEF) and lower left ventricular diastolic diameter. During follow-ups, 1375 (22%) men and 925 (18.4%) women died. Cumulative incidence of death was higher in men with HFrEF but similar for HFmrEF and HFpEF. Cox regression for death showed renal dysfunction, stroke, diabetes, atrial fibrillation, age, LVEF, valve disease, MI, and hypertensive CMP as independent death predictors for all HF patients. Conclusions: Women had a better prognosis than men in HFrEF and similar mortality for HFmrEF and HFpEF, but sex was not an independent predictor of death for all HF subtypes.
Palavras-chave
heart failure, cardiomyopathy, left ventricular ejection fraction, prognosis, women, men
URI
https://observatorio.fm.usp.br/handle/OPI/51441
Referências
  1. Alenazy B, 2019, ESC HEART FAIL, V6, P1283, DOI 10.1002/ehf2.12525
  2. Arruda Vilmeyze Larissa de, 2022, Rev Bras Epidemiol, V25, pE220021, DOI 10.1590/1980-549720220021.2
  3. Beale AL, 2018, CIRCULATION, V138, P198, DOI 10.1161/CIRCULATIONAHA.118.034271
  4. Bibbins-Domingo K, 2004, J AM COLL CARDIOL, V44, P1593, DOI 10.1016/j.jacc.2004.07.040
  5. Brasil. Receita Federal, 2022, BRASILIA
  6. Butler J, 2022, CIRCULATION, V146, P1046, DOI 10.1161/CIRCULATIONAHA.122.059755
  7. De Bellis A, 2020, HEART FAIL REV, V25, P245, DOI 10.1007/s10741-019-09824-y
  8. Dewan P, 2019, J AM COLL CARDIOL, V73, P29, DOI 10.1016/j.jacc.2018.09.081
  9. Dunlay Shannon M, 2012, Curr Heart Fail Rep, V9, P267, DOI 10.1007/s11897-012-0107-7
  10. Farre N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018719
  11. Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924
  12. Grupper A, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.1012361
  13. Ho J.E, 2015, CIRCULATION, V132, pA11958, DOI [10.1161/circ.132.suppl_3.11958, DOI 10.1161/CIRC.132.SUPPL_3.11958]
  14. Ho JE, 2012, EUR HEART J, V33, P1734, DOI 10.1093/eurheartj/ehs070
  15. Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066
  16. Koh AS, 2017, EUR J HEART FAIL, V19, P1624, DOI 10.1002/ejhf.945
  17. Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x
  18. Lam CSP, 2012, CIRC-HEART FAIL, V5, P571, DOI 10.1161/CIRCHEARTFAILURE.112.970061
  19. Li Le, 2023, Int J Cardiol, V371, P191, DOI 10.1016/j.ijcard.2022.09.064
  20. Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F
  21. Lund LH, 2018, EUR J HEART FAIL, V20, P1230, DOI 10.1002/ejhf.1149
  22. Madan N, 2019, HEART FAIL CLIN, V15, P55, DOI 10.1016/j.hfc.2018.08.006
  23. Magnussen C, 2019, JACC-HEART FAIL, V7, P204, DOI 10.1016/j.jchf.2018.08.008
  24. Martinez-Selles M, 2012, EUR J HEART FAIL, V14, P473, DOI 10.1093/eurjhf/hfs026
  25. MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
  26. Oneglia Andrew, 2020, Curr Heart Fail Rep, V17, P409, DOI 10.1007/s11897-020-00487-7
  27. Pandey A, 2018, CIRCULATION, V137, P1814, DOI 10.1161/CIRCULATIONAHA.117.031622
  28. Rodgers JL, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6020019
  29. Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344
  30. Savarese G, 2022, CARDIOVASC RES, DOI 10.1093/cvr/cvac013
  31. Savarese G, 2022, NAT REV CARDIOL, V19, P100, DOI 10.1038/s41569-021-00605-5
  32. Savarese G, 2019, JACC-HEART FAIL, V7, P306, DOI 10.1016/j.jchf.2018.11.019
  33. Spitaleri G, 2022, J CLIN MED, V11, DOI 10.3390/jcm11030784
  34. Stolfo D, 2019, JACC-HEART FAIL, V7, P505, DOI 10.1016/j.jchf.2019.03.011
  35. Thompson LE, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005801
  36. Tsao CW, 2018, JACC-HEART FAIL, V6, P678, DOI 10.1016/j.jchf.2018.03.006
  37. Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485
  38. Wang Xiaowen, 2022, Circulation, DOI 10.1161/CIRCULATIONAHA.122.062832
  39. Zhao Z, 2014, AM J PHYSIOL-HEART C, V306, pH628, DOI 10.1152/ajpheart.00859.2013

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03